Tred Avon Family Wealth’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Sell
5,183
-5,487
-51% -$298K 0.07% 256
2026
Q1
$670K Buy
10,670
+2,155
+25% +$172K 0.22% 137
2025
Q4
$812K Buy
8,515
+4,161
+96% +$408K 0.26% 108
2025
Q3
$425K Buy
+4,354
New +$451K 0.15% 168

Other funds holding BSX

Tred Avon Family Wealth's BSX Position: Q2 2026 in Review

Tred Avon Family Wealth reduced its Boston Scientific (BSX) stake by 51% in Q2 2026, selling an estimated $298K and leaving 5,183 shares worth $221K. The position accounts for 0.07% of the portfolio, ranked #256.

Tred Avon Family Wealth first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. The position peaked at $812K in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Tred Avon Family Wealth held 5,183 shares of Boston Scientific worth $221K as of Q2 2026.
  • Tred Avon Family Wealth sold 5,487 Boston Scientific shares in Q2 2026, an estimated $298K.
  • Boston Scientific made up 0.07% of Tred Avon Family Wealth's portfolio in Q2 2026, its #256 holding.
  • Tred Avon Family Wealth first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
  • Tred Avon Family Wealth's Boston Scientific position peaked at $812K in Q4 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Tred Avon Family Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.